Operator

Hello, everyone, and welcome to the PharmaMar LAGOON Trial Conference Call. My name is Carla, and I will be coordinating your call today. [Operator Instructions]

I would now like to hand the call over to José Luis Moreno, Vice President, Head of Capital Markets and Investor Relations, to begin. Please go ahead when you're ready.

José Martinez-Losa
Head of Capital Markets & Investor Relations

Thank you, Carla, and good afternoon to everyone, and thank you for joining us today for the LAGOON trial conference call. On the call with me today are Luis Mora, Managing Director of PharmaMar; José Antonio López-Vilariño, Global Product Lead of Oncology; and Pascal Besman, Senior Vice President of Strategic Development.

And after comments, we will open the floor for your questions, and we will take the written questions. Let me just make -- mention that all these written questions, questions only related to the topic today, which is the LAGOON trial. And before we begin, please note that our full safe harbor statement is available in the corporate presentation in our website, together with the press release about the results of LAGOON issued on Friday. And we undertake no obligation to update these statements, except as required by the applicable law.

Pascal?